Position in TNGX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$37,968,802
+$37,961,397 QoQ
Shares Held
1,214,613
+343011.0% QoQ
Ownership
0.720%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#38
of 247 holders
Holding Since
Mar 2023
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TNGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FEDERATED HERMES, INC. holds $2,455,215,104 across 149 Biotechnology names. TNGX ranks #22 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
719,905 | $216,713,000 | |
| 2 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,785,716 | $198,268,046 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,884 | $160,177,448 | |
| 4 | MRNA |
Moderna, Inc.
|
1,794,778 | $125,688,301 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
749,398 | $85,933,468 | |
| 6 | EYPT |
EyePoint, Inc.
|
5,681,052 | $81,239,042 | |
| 7 | ARGX |
Argenx SE
|
87,288 | $80,983,187 | |
| 8 | ZBIO |
Zenas BioPharma, Inc.
|
3,116,805 | $79,104,510 |
All Filings in TNGX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $37,968,802 | 1,214,613 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $7,405 | 354 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $3,207 | 362 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $3,040 | 362 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $1,853 | 362 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $10,388 | 7,583 | Shares | Defined | 2025-05-08 | |
| 2024-03-31 | $532,893 | 67,115 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $1,544 | 156 | Shares | Defined | 2024-01-31 | |
| 2023-03-31 | $1,627 | 412 | Shares | Defined | 2023-05-08 | |
| No filing history on record for this holder in this stock. | ||||||